Biography

Prof. Salah Aref
Hematology Unit, Mansoura Cancer Institute,
Mansoura University, Egypt
Professor


Email: [email protected]


Qualifications

1993  MD., Hematology, Mansoura faculty of Medicine, Egypt
1989  M.Sc., Hematology, Mansoura faculty of Medicine, Egypt
1983  MB Bch, Medicine, Egypt


Publications(Selected)

  1. S. Aref, L. Ebrahim, A. Bassam. Platelets associated antibodies pre and post splenectomy in Hepatitis C patients with thrombocytopenia. Accepted in hematology journal, 20011.
  2. S. Aref, D. Abdullah, M. Fouda, N. El Menshawy, E. Azmy, A. Bassam, A. Menessy, M. El Refaie. Neutrophil apoptosis in neutropenic patients with Hepatitis C infection: Role of Caspases 3, 10, and GM-CSF. Indian j of hematology and blood transfusion 27(2): pp. 81-87, 2011.
  3. S. Aref , T. Sleem, N. El Menshawy, L. Ebrahiem, D. Abdella, M. Fouda, N.A. Samara, A. Menessy, H. Abdel-Ghaffar, A. Bassam, M. Abdel Wahaab. Antiplatelet antibodies contribute to thrombocytopenia associated with chronic hepatitis C virus infection. Hematology. 2009 Oct; 14(5): pp. 277-281, 2009.
  4. S. Aref, T. Selim, L. Ibrahim, H. Abdel Ghaffar, R. El – Ashery . Flow cytometry detection of Platelets autoantibodies in children with idiopathic thrombocytopenic purpura. Indian journal of Hematology and blood transfusion; 25 (3): pp. 53-58, 2009.
  5. S. Aref , T. Sleem , N. EL Menshawy , L. Ebrahiem , D. Abdella , M. Fouda , N. Abou Samara , A. Menessy , H. Abdel-Ghaffar , A. Bassam , M Abdel Wahaab. Antiplatelet antibodies contribute to thrombocytopenia associated with chronic hepatitis C virus infection. Hematology; 14(5): pp. 277-281, 2009.
  6. S. Aref, E. Abdel-Khalek, I. Abdel-Aal , M El Refaie. Circadian pattern of acute variceal bleeding among cirrhotic Egyptian patients. Indian journal of Hematology and blood transfusion; 25( 2 ): pp. 53-58, 2009.
  7. S. Aref, N. El Menshawy, E. Azmy , M. El-Refaie. Soluble angiopoietin-2/sTie2 receptor ratio is an independent prognostic marker in adult acute myeloid leukemia. Indian journal of Hematology and blood transfusion; 25(1): pp. 17-22, 2009.
  8. S. Aref, M. El-Sherbiny, E. Azmy, T. Goda, T. Selim, M. El-Refaie, E. Twafik. Elevated serum endostatin levels are associated with favorable outcome in acute myeloid leukemia. Hematology. 13(2): pp. 95-100, 2008.
  9. S. Aref, O. Salama, S. Shamaa, M. El-Refaie, H. Mourkos. Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia. Hematology. 12(4): pp. 319-324, 2007.
  10. S. Aref, E. Osman, S. Mansy, N. Omer, E. Azmy, T. Goda, M. El-Sherbiny. Prognostic relevance of circulating matrix metalloproteinase-2 in acute myeloid leukaemia patients. Hematol Oncol. 25(3): pp. 121-126, 2007.
  11. S. Aref, M. Mabed, M. El-Sherbiny, T. Selim, A. Metwaly. Cyclin D1 expression in acute leukemia. Hematology.11 (1): pp. 31-34, 2006.
  12. S. Aref, O. salama, T, Goda. H. Mourkos. B-cells from CLL and ALL are Capable of synthesis of VEGF and b-FGF. Haema Journal, 2006.
  13. Settin, M. Al Haggar, T. Al Dosoky, R. Al Baz, N. Abdelrazik, M. Fouda, S. Aref, Y. Al-Tonbary. Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia: cases from Mansoura, Egypt. Hematology. 11(5): pp. 341-349, 2006.
  14. S. Aref, Y. Mossad, T. El-Khodary, M. Awad, E. El-Shahat. Cyclin Dl expression in B-cell non Hodgkin lymphoma. Hematology. 11(5): pp. 365-370, 2006.
  15. S. Aref, M. Sakrana, A. Abdel Hafez, M. Hamdy. Soluble P-selectin levels in diabetes mellitus patients with coronary artery disease. Hematology; 10(3): pp. 183-187, 2005.
  16. S. Aref, M. El Sherbiny, T. Goda, M. Fouda, H. Al Askalany, M. Mabed . Soluble VEGF/sFLt1 ratio is independent predictor of AML patient out come. Hematology, 10(2): pp. 131:134, 2005.
  17. S. Aref, M. Mabed, T. Selim, T. Goda, N. Khafagy. Thrombopoietin (TPO) Levels in Hepatic patients with thrombocytopenia. Hematology. 2004 Oct-Dec; 9(5-6): pp. 351-356, 2004.
  18. M. Mabed, S. Aref, M. Fouda, S. El-Sharawy. Chlorambucil Plus Theophylline vs Chlorambucil Alone as a Front Line Therapy for B-Cell Chronic Lymphatic Leukemia. Leukemia&Lymphoma; 45 (10): pp. 2029-2035, 2004.
  19. S. Aref, M. El Refaei, T. Goda, M. Sakrana, H. El-Nemre. Accelerated neutrophil apoptosis in neutropenic patients with hepatosplenic schistosomiasis is induced by serum Fas ligand. The Hematology; 5 (5): pp. 434-439, 2004.
  20. S. Aref, O. Salama, Y. Al-Tonbary, A. Mansour. Assessment of Bcl-2 expression as modulator of Fas mediated apoptosis in acute leukemia. Hematology; 9(2): pp. 113-121, 2004.
  21. S. Aref, M. Mabed, K. Zalata, M. Sakrana, H. Al-Askalany. The interplay between c-Myc oncogene expression and circulating VEGF, its antagonist receptor, soluble Flt-1 in diffuse large B cells lymphoma (DLBCL): Relationship to patient outcome. Leukemia & Lymphoma; 45(3): pp. 499-506, 2004.
  22. S. Aref, M.F. El Refaei, M. Sakrana, H. El-Nemre. Enhanced neutrophil apoptosis in Neutropenic Patients with hepatosplenic Schistosomiasis: Evidence of Serum Fas Ligand. Hematology; 9(1) 71: pp. 78, 2004.
  23. S. Aref, T. Goda, M. El-Sherbiny. Syndecan-1 in multiple Myeloma: Relationship to conventional prognostic factors. Hematology, 8(4): pp. 221-228, 2003.
  24. S. Aref, M.El-Sherbiny, M. Mabed, A. Menessy, M. El-Refaei. Urokinase Plasminogen activator Receptor; soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: A possible relation to disease invasion. Hematology; 8(6): pp. 385-392, 2003.
  25. M. Mabed, S. Aref, D. Aladle. Hepatocellular carcinoma of a short malignant transformation time in a patient with acute myeloblastic leukemia. Annals of Hematology, 82(5): pp. 318-320, 2003.
  26. S. Aref, M. Fouda, E. El Dosoky, M. Mabed, A. Menessy, M. Saleeb, K. Zalata. C-Myc oncogene expression and Cdc25A cell activating phosphates in non-Hodgkin lymphoma. Hematology; 8(1): pp. 183-190, 2003.
  27. S. Aref, L. Mahmoud, M. El-Refie, M. Abdel Wahaab, N. Abou Samara. Assessment of neutrophil apoptosis ex vivo in hepatosplenic patients with neutropenia pre and post splenectomy. Hematology; 8(4): pp. 265-272, 2003.
  28. S. Aref, M. Mabed, M. Sakrana, T. Goda, M. El- Sherbiny. Soluble hepatocyte growth factor and vascular endothelial growth factor in adult acute myeloid leukemia: Relationship to disease characteristics. Hematology; 7(5): pp. 273-279, 2002.
  29. S. Aref, O. Salama , Y. Al tonbary, M. Fouda, A. Menessy, M. El-Sherbiny. L and E selectins in acute myeloid leukemia: Expression clinical relevance and relation to patient out come.Hematology; 7(2): pp. 83-87, 2002.
SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top